PHK
PTCT icon

Point72 Hong Kong’s PTC Therapeutics PTCT Stock Holding History

Point72 Hong Kong’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,000
Closed -$244K – 608
2025
Q2 		$244K Sell
5,000
-17,273
-78% -$820K 0.02% 291
2025
Q1 		$1.14M Sell
22,273
-10,163
-31% -$507K 0.07% 195
2024
Q4 		$1.46M Buy
32,436
+21,034
+184% +$900K 0.09% 160
2024
Q3 		$423K Sell
11,402
-46,128
-80% -$1.54M 0.03% 254
2024
Q2 		$1.76M Buy
57,530
+48,307
+524% +$1.56M 0.11% 155
2024
Q1 		$268K Buy
+9,223
New +$258K 0.01% 384
2022
Q4 		– Sell
-8,305
Closed -$417K – 1320
2022
Q3 		$417K Buy
8,305
+4,283
+106% +$210K 0.01% 806
2022
Q2 		$161K Buy
+4,022
New +$141K 0.01% 1043
2022
Q1 		– Sell
-2,804
Closed -$112K – 2241
2021
Q4 		$112K Buy
+2,804
New +$107K ﹤0.01% 1155
2021
Q3 		– Sell
-624
Closed -$26K – 2354
2021
Q2 		$26K Buy
624
+216
+53% +$9.26K ﹤0.01% 1591
2021
Q1 		$19K Buy
+408
New +$24.2K ﹤0.01% 1486
2019
Q4 		– Sell
-808
Closed -$27K – 1399
2019
Q3 		$27K Buy
+808
New +$35.2K 0.01% 668
2018
Q4 		– Sell
-2,924
Closed -$137K – 1145
2018
Q3 		$137K Buy
+2,924
New +$121K 0.05% 282
2018
Q2 		– Sell
-1,276
Closed -$35K – 1129
2018
Q1 		$35K Buy
+1,276
New +$32.3K 0.02% 534
2017
Q2 		– Sell
-2,388
Closed -$23K – 996
2017
Q1 		$23K Buy
2,388
+2,340
+4,875% +$28.3K 0.03% 382
2016
Q4 		$1K Buy
+48
New +$504 ﹤0.01% 818

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Hong Kong's PTCT Position: Q3 2025 in Review

Point72 Hong Kong sold out of PTC Therapeutics (PTCT) in Q3 2025, closing a stake of 5,000 shares — an estimated $244K sold.

Point72 Hong Kong first reported a position in PTCT in Q4 2016 and held it in 16 quarters. The position peaked at $1.76M in Q2 2024. 294 funds tracked by Wall St. Rank hold PTCT as of Q3 2025.

  • Point72 Hong Kong reported no remaining PTC Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 5,000 PTC Therapeutics shares in Q3 2025, an estimated $244K.
  • Point72 Hong Kong first reported a position in PTC Therapeutics in Q4 2016 and held it in 16 quarters.
  • Point72 Hong Kong's PTC Therapeutics position peaked at $1.76M in Q2 2024.
  • 294 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.